Postdoctoral Position Available: Research opportunities in biological and behavioral drivers of aging and neurodegenerative disease
January 13, 2025
We are seeking curious, interdisciplinary postdoctoral fellows to contribute to ongoing clinical research and pursue related areas of their own focus on the Brain Aging for Cognitive Health (BrANCH) Team. Interest in clinical training is not required but available for qualified neuropsychology... Dr. Kaitlin Casaletto - Sex Differences Across Neurodegenerative Diseases: Lessons in Resistance and Resilience
July 08, 2024
Kaitlin Casaletto, PhD is an Associate Professor of Neuropsychology and investigator on the BrANCH study. In July 2024, Dr. Casaletto gave a presentation titled "Sex Differences Across Neurodegenerative Diseases: Lessons in Resistance and Resilience" as a part of the Ann S. Bowers Women's Brain... FDA approves lecanemab to treat adults with Alzheimer’s disease
July 06, 2023
On July 6, 2023, the Food and Drug Administration (FDA) granted full approval to lecanemab (marketed as Leqembi™) to treat people in the earliest symptomatic stages of Alzheimer’s disease. This is the first disease-modifying therapy approved for the treatment of Alzheimer’s disease in the United... Neuropsychology Postdoctoral Fellowships for 2023-2025
September 17, 2022
The University of California, San Francisco Memory and Aging Center (MAC) is offering several Neuropsychology Postdoctoral Fellowships for 2023-2025. We are looking for candidates invested in a scientist-practitioner model. We have flexibility to design the Fellowship around the individual Fellow’s... Funding Opportunity Announcement
By Michelle You on June 01, 2020
Hillblom Aging Network Kickstart Grants
COVID-19 Resources
April 08, 2020
UCSF COVID-19 Website
CDC Website
Alzheimer's Association Programs and Support
Positivity and Good News
Dr. Kramer Receives Endowed Chair from the John Douglas French Alzheimer's Association
February 28, 2020
awarded by the John Douglas French Alzheimer's Foundation